Arch Therapeutics Inc: Business description, financial summary, 3yr and interim financials, key statistics/ratios and historical ratio analysis.
Provider: Reuters Investment Profile
NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.
Arch Therapeutics Inc secures $2.85 mln private placement
Arch Therapeutics Inc:Closes a previously announced private placement to accredited individual and institutional investors.Says transaction provided about $2.77 mln of net proceeds to the company, after expenses.Intends to use the offering proceeds to advance its hemostasis development program, predominantly focusing on AC5 Surgical Hemostatic Device, and for general corporate purposes.Says it did not engage a placement agent in connection with the private placement.
Latest Developments for Arch Therapeutics Inc
Latest Key Developments in Medical
- Share this
- Digg this